THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the morbidity...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	сhronic heart failure randomized clinical trial ivabradine omega-3 polyunsaturated fatty acids
Online Access:	https://www.rpcardio.online/jour/article/view/561
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis
by: O. A. Rubanenko, et al.
Published: (2023-03-01)

Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
by: S. N. Tereshchenko, et al.
Published: (2024-05-01)

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)

NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION
by: A. I. Martinov, et al.
Published: (2016-01-01)

Biophysical modeling indicates a high affinity of ethyl esters of omega-3 polyunsaturated fatty acids to the enzymes of the pro-inflammatory arachidonic acid cascade
by: I. Yu. Torshin, et al.
Published: (2022-07-01)

Chronic kidney disease in patients with psoriasis, chronic opisthorchiasis and at their combination
by: T. A. Kolosovskaya, et al.
Published: (2009-08-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

OMEGA-3 IN PEDIATRIC PRACTICE
by: M. I. Ivardava
Published: (2012-12-01)

New perspectives in improving prognosis after myocardial infarction
by: N. M. Akhmedzhanov
Published: (2006-06-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Nutraceutical support in the prevention and treatment of cardiovascular diseases
by: E. V. Gracheva, et al.
Published: (2023-07-01)

Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year
by: N. G. Gogolashvili, et al.
Published: (2011-10-01)

Association between the dietary omega-6 to omega-3 fatty acid ratio and age-related macular degeneration in Korean adults
by: Won Jang, et al.
Published: (2025-03-01)

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics
by: G. P. Arutyunov, et al.
Published: (2019-05-01)

PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
by: V. P. Mikhin, et al.
Published: (2017-12-01)

Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women
by: D. A. Napalkov, et al.
Published: (2024-06-01)

Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems
by: M. I. Kislova, et al.
Published: (2021-07-01)

LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-VESSEL LESION CORONARY ATHEROSCLEROSIS
by: M. N. Sin’kova, et al.
Published: (2014-12-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)

Role of omega-3 unsaturated acids in prevention and treatment of different diseases (part 2)
by: M. N. Sinkova, et al.
Published: (2021-06-01)

Omega-3 index of erythrocytes and predictors of sudden cardiac death in patients with coronary heart disease and ventricular arrhythmias
by: E. M. Gavva, et al.
Published: (2012-08-01)

The role of fatty acids in attention deficit hyperactivity disorder
by: Fatih Gültekin, et al.
Published: (2022-08-01)

Analysis of fatty acid profiles of micronutrients and pharmaceuticals based on omega-3 polyunsaturated fatty acid extracts from natural sources
by: I. Yu. Torshin, et al.
Published: (2023-09-01)

Aquaculture as a source of functional food
by: A. V. Zhigin, et al.
Published: (2021-12-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Structural biology of lipoxygenases: current knowledge and further development
by: I. V. Ivanov, et al.
Published: (2014-08-01)

Nutraceutical eicosapentaenoic acid in treatment-resistant depression: The psychoneuroimmunity and clinical implications
by: Jane Pei-Chen Chang, et al.
Published: (2025-08-01)

The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders
by: V. I. Podzolkov, et al.
Published: (2020-07-01)

The first thousand days of life are the basis of metabolic programming. How to help with artifi cial feeding?
by: A. V. Polyanskaya, et al.
Published: (2023-12-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

The association between the intake of polyunsaturated fatty acids and chronic constipation and diarrhea: NHANES 2005–2010
by: Ping Lin, et al.
Published: (2025-05-01)

Ratio of Linoleic and Alpha-Linolenic Acids and Vitamin E: The Productive Performance, Serum Biochemical Profile, and Yolk Composition of Japanese Quail Breeders
by: LAL Silva, et al.
Published: (2025-07-01)

Comparative assessment for efficiency of isolation of arachidonic acid (20:4n-6) from various sources
by: Ruslan M. Sultanov, et al.
Published: (2016-09-01)

Cooking for disability: a pilot study on nutritional interventions for mental health support in adults with autism spectrum disorder
by: Johanna Maria Catharina Blom, et al.
Published: (2025-08-01)

New Clinical Aspects of Eplerenone Use in Clinical Practice
by: S. R. Gilyarevskiy, et al.
Published: (2018-09-01)

Principles of diet therapy for sarcopenic obesity: A review
by: Е. V. Pavlovskaya, et al.
Published: (2025-01-01)

ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis
by: Yulang Jiang, et al.
Published: (2025-08-01)

Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases
by: A. N. Zakirova, et al.
Published: (2022-05-01)